Patient Experience in Early-Stage Parkinson’s Disease: Using a Mixed Methods Analysis to Identify Which Concepts Are Cardinal for Clinical Trial Outcome Assessment
Thomas Morel(UCB Pharma (Belgium)), Karlin Schroeder(Parkinson's Foundation), William S. Brooks(Parkinson's Foundation), Carroll Siu(Parkinson's UK), Ashley F. Slagle, Stefan Cano, Kate Trenam(UCB Pharma (Belgium)), Natasha Ratcliffe(Parkinson's UK), Casey Gallagher(Parkinson's Foundation), Paul Burns(University of Mississippi Medical Center), Lesley Gosden(Parkinson's UK), Roger A. Barker(University of Cambridge), Babak Boroojerdi(UCB Pharma (Germany)), John Andrejack(Parkinson's Foundation), Geraldine Blavat(Parkinson's Foundation), Sophie Cleanthous
Cited by 45
Related Papers
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data
|The Lancet Neurology|2017|318
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
|New England Journal of Medicine|2025|203
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
|The Lancet Neurology|2017|189